Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,392 | $2,470 | $2,345 | $2,998 |
| - Cash | $1,308 | $1,727 | $1,134 | $1,181 |
| + Debt | $21,021 | $21,738 | $21,510 | $21,616 |
| Enterprise Value | $22,106 | $22,481 | $22,721 | $23,433 |
| Revenue | $912 | $2,530 | $2,259 | $2,559 |
| % Growth | -64% | 12% | -11.7% | – |
| Gross Profit | $1,580 | $1,766 | $1,558 | $1,832 |
| % Margin | 173.2% | 69.8% | 69% | 71.6% |
| EBITDA | $2,520 | $764 | $602 | $901 |
| % Margin | 276.3% | 30.2% | 26.6% | 35.2% |
| Net Income | $179 | $148 | -$58 | $93 |
| % Margin | 19.6% | 5.8% | -2.6% | 3.6% |
| EPS Diluted | -0.24 | 0.4 | -0.16 | 0.25 |
| % Growth | -160% | 350% | -164% | – |
| Operating Cash Flow | $405 | $289 | $211 | $601 |
| Capital Expenditures | -$91 | -$99 | -$124 | -$107 |
| Free Cash Flow | $314 | $190 | $87 | $494 |